StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
10
Publishing Date
2023 - 10 - 30
1
2023 - 10 - 12
1
2023 - 07 - 18
1
2023 - 06 - 20
1
2022 - 07 - 07
1
2022 - 01 - 25
1
2021 - 10 - 05
1
2021 - 07 - 30
1
2021 - 05 - 21
1
2021 - 03 - 16
1
Sector
Health technology
10
Tags
Alzheimer
9
Alzheimer's
19
Alzheimer's disease
6
Alzheimer’s
14
Announcement
2
Anvs401
8
Application
3
Approval
1
Association
1
Authorization
1
Biomarkers
1
Biotech
1
Biotechnology
2
Buntanetap
12
Ceo
5
Chip
1
Clinical trials
4
Clinical-trials-phase-ii
7
Clinical-trials-phase-iii
5
Conference
19
Day
1
Dementia
1
Disease
29
Drug
3
Events
13
Fda
3
Financial
3
Growth
1
Health
1
Huntington’s disease
1
Infections
1
Infectious disease
1
International
6
Iot
1
Leo
2
Money
3
N/a
46
Parkinson
7
Parkinson's
6
Parkinson’s
3
Patent
7
People
3
Pharm-country
16
Pharmaceutical
4
Phase 2
7
Phase 2b
2
Phase 3
2
Posiphen
2
Positive
10
Potential
2
Presentation
4
Publication
4
Research
4
Results
7
Study
9
Train
2
Treatment
11
Trial
11
Trials
4
Update
9
Entities
Abbvie inc.
31
Adial pharmaceuticals, inc
10
Alnylam pharmaceuticals, inc.
19
Amgen inc.
14
Amplitude healthcare acquisition corp
9
Annovis bio, inc.
10
Aquestive therapeutics, inc.
18
Arrival
21
Astellas pharma inc
14
Astrazeneca plc
13
Beigene, ltd.
19
Beyondspring, inc.
11
Biogen inc.
13
Biontech se
17
Bridgebio pharma, inc.
16
Bristol-myers squibb company
27
Celldex therapeutics, inc.
10
Clearside biomedical, inc.
15
Coherus biosciences, inc.
21
Dare bioscience, inc.
13
Eli lilly and company
30
Equillium, inc.
9
Fortress biotech, inc.
10
Gartner, inc.
12
Gilead sciences, inc.
13
Glaxosmithkline plc
12
Halozyme therapeutics, inc.
9
Hoth therapeutics, inc.
14
I-mab
9
Immix biopharma, inc.
10
Immutep limited
11
Incyte corporation
15
Ionis pharmaceuticals, inc.
21
Johnson & johnson
46
Kering
11
Lithium corp
14
Mediwound ltd.
11
Merck & company, inc.
19
Morgan stanley
10
Myovant sciences ltd.
10
Nasdaq, inc.
42
Novartis ag
19
Orange
21
Pfizer, inc.
45
Pliant therapeutics, inc.
10
Redhill biopharma ltd.
10
Regeneron pharmaceuticals, inc.
26
Regenxbio inc.
17
Rocket pharmaceuticals, inc.
11
Sanofi
103
Scynexis, inc.
11
Sellas life sciences group, inc.
11
Sorrento therapeutics, inc.
19
Takeda pharmaceutical company limited
14
Taylor devices, inc.
17
Teva pharmaceutical industries ltd
14
Tonix pharmaceuticals holding corp.
12
Transcode therapeutics inc
10
Vertex pharmaceuticals incorporated
11
Veru inc.
10
Symbols
ANVS
10
Exchanges
Amex
10
Crawled Date
2023 - 10 - 30
1
2023 - 10 - 12
1
2023 - 07 - 18
1
2023 - 06 - 20
1
2022 - 07 - 07
1
2022 - 01 - 25
1
2021 - 10 - 05
1
2021 - 07 - 30
1
2021 - 05 - 21
1
2021 - 03 - 16
1
Crawled Time
12:00
2
14:15
1
14:20
1
16:00
1
17:00
2
18:00
1
21:00
1
23:00
1
Source
www.biospace.com
8
www.globenewswire.com
1
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Positive
entities :
Annovis bio, inc.
save search
Annovis Bio Receives Positive Recommendation to Continue Phase 2/3 Trial of Buntanetap for Alzheimer’s Disease Patients From the Independent Data and Safety Monitoring Board (DSMB)
Published:
2023-10-30
(Crawled : 23:00)
- biospace.com/
ANVS
|
$9.85
9.57%
1.52%
240K
|
Health Technology
|
22.97%
|
O:
-0.12%
H:
3.62%
C:
1.88%
disease
alzheimer’s
positive
buntanetap
trial
Annovis Bio Announces Positive Interim Independent Analysis for Statistical Power in Its Alzheimer’s Study
Published:
2023-10-12
(Crawled : 12:00)
- globenewswire.com
ANVS
|
$9.85
9.57%
1.52%
240K
|
Health Technology
|
27.92%
|
O:
3.9%
H:
17.44%
C:
5.13%
alzheimer’s
positive
study
Continued Positive Performance of Novel Drug Development by Annovis Bio Presented at 2023 Alzheimer's Association International Conference
Published:
2023-07-18
(Crawled : 14:20)
- biospace.com/
ANVS
|
$9.85
9.57%
1.52%
240K
|
Health Technology
|
-27.14%
|
O:
1.63%
H:
1.99%
C:
0.36%
drug
conference
association
positive
international
alzheimer's
Annovis Bio Receives Excellent Safety Rating and Positive Recommendation to Continue Phase III Trial of Buntanetap for Parkinson’s Disease Patients from the Independent Data and Safety Monitoring Board (DSMB)
Published:
2023-06-20
(Crawled : 21:00)
- biospace.com/
ANVS
|
$9.85
9.57%
1.52%
240K
|
Health Technology
|
-31.45%
|
O:
-0.97%
H:
9.35%
C:
6.25%
disease
positive
buntanetap
parkinson’s
trial
Annovis Bio Announces Positive FDA Notice For Buntanetap Phase 3 Clinical Trial In Parkinson's Disease
Published:
2022-07-07
(Crawled : 12:00)
- prnewswire.com
ANVS
|
$9.85
9.57%
1.52%
240K
|
Health Technology
|
-25.72%
|
O:
11.24%
H:
7.12%
C:
1.69%
fda
disease
trial
positive
buntanetap
anvs401
posiphen
phase 3
Annovis Bio Announces Positive FDA Feedback for Buntanetap Phase 3 Clinical Development in Parkinson's Disease
Published:
2022-01-25
(Crawled : 17:00)
- biospace.com/
ANVS
|
$9.85
9.57%
1.52%
240K
|
Health Technology
|
-28.73%
|
O:
2.75%
H:
5.63%
C:
-1.27%
fda
parkinson
disease
positive
phase 3
buntanetap
Annovis Bio Announces Positive Phase 2 Efficacy Data for the Treatment of Parkinson's Disease
Published:
2021-10-05
(Crawled : 14:15)
- biospace.com/
ANVS
|
$9.85
9.57%
1.52%
240K
|
Health Technology
|
-67.55%
|
O:
3.69%
H:
5.15%
C:
-16.27%
disease
treatment
phase 2
positive
parkinson
Annovis Bio Pleased by Positive Interim Results from Ongoing Phase II Clinical Trials of ANVS401 (Posiphen) for the Treatment of Alzheimer's Disease and Parkinson's Disease
Published:
2021-07-30
(Crawled : 16:00)
- biospace.com/
ANVS
|
$9.85
9.57%
1.52%
240K
|
Health Technology
|
-77.36%
|
O:
-13.77%
H:
0.0%
C:
0.0%
disease
alzheimer
treatment
ongoing
clinical trials
positive
results
parkinson
trial
alzheimer’s
alzheimer's disease
alzheimer's
posiphen
anvs401
Annovis Bio Announces Positive Phase 2 Data - ANVS401 Improves Cognition in Alzheimer's Disease - Patients' Cognition Improved 3.3 Points on ADAS-Cog11
Published:
2021-05-21
(Crawled : 18:00)
- biospace.com/
ANVS
|
$9.85
9.57%
1.52%
240K
|
Health Technology
|
-62.69%
|
O:
39.81%
H:
165.43%
C:
62.56%
disease
alzheimer
phase 2
positive
alzheimer’s
alzheimer's disease
alzheimer's
anvs401
Annovis Bio Announces Positive Phase 2 Data - Interim Data Shows ANVS401 Improves Speed and Coordination in Parkinson's Patients
Published:
2021-03-16
(Crawled : 17:00)
- biospace.com/
ANVS
|
$9.85
9.57%
1.52%
240K
|
Health Technology
|
-71.03%
|
O:
19.94%
H:
17.68%
C:
-18.34%
phase 2
positive
parkinson
anvs401
Gainers vs Losers
60%
40%
Top 10 Gainers
AGBA
|
News
|
$1.03
157.5%
57.94%
120M
|
Finance
ZCMD
|
$1.45
5.84%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.52
100.0%
51.13%
5M
|
Health Technology
ISPC
|
$0.421
97.65%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.5
45.65%
470K
|
OST
|
$0.509
23.81%
45.26%
90K
|
GDHG
|
$0.263
21.76%
40.66%
3.1M
|
XPON
|
News
|
$3.15
63.21%
37.74%
16M
|
TIRX
|
$0.8
65.02%
30.74%
58M
|
BNTC
|
News
|
$6.82
42.08%
30.64%
3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.